Application of Transcriptomics for Predicting Protein Interaction Networks, Drug Targets and Drug Candidates

IF 2.7 Q3 ENGINEERING, BIOMEDICAL Frontiers in medical technology Pub Date : 2022-03-09 DOI:10.3389/fmedt.2022.693148
Dulshani Kankanige, L. Liyanage, M. O’Connor
{"title":"Application of Transcriptomics for Predicting Protein Interaction Networks, Drug Targets and Drug Candidates","authors":"Dulshani Kankanige, L. Liyanage, M. O’Connor","doi":"10.3389/fmedt.2022.693148","DOIUrl":null,"url":null,"abstract":"Protein interaction pathways and networks are critically-required for a vast range of biological processes. Improved discovery of candidate druggable proteins within specific cell, tissue and disease contexts will aid development of new treatments. Predicting protein interaction networks from gene expression data can provide valuable insights into normal and disease biology. For example, the resulting protein networks can be used to identify potentially druggable targets and drug candidates for testing in cell and animal disease models. The advent of whole-transcriptome expression profiling techniques—that catalogue protein-coding genes expressed within cells and tissues—has enabled development of individual algorithms for particular tasks. For example,: (i) gene ontology algorithms that predict gene/protein subsets involved in related cell processes; (ii) algorithms that predict intracellular protein interaction pathways; and (iii) algorithms that correlate druggable protein targets with known drugs and/or drug candidates. This review examines approaches, advantages and disadvantages of existing gene expression, gene ontology, and protein network prediction algorithms. Using this framework, we examine current efforts to combine these algorithms into pipelines to enable identification of druggable targets, and associated known drugs, using gene expression datasets. In doing so, new opportunities are identified for development of powerful algorithm pipelines, suitable for wide use by non-bioinformaticians, that can predict protein interaction networks, druggable proteins, and related drugs from user gene expression datasets.","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"74 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in medical technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fmedt.2022.693148","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 1

Abstract

Protein interaction pathways and networks are critically-required for a vast range of biological processes. Improved discovery of candidate druggable proteins within specific cell, tissue and disease contexts will aid development of new treatments. Predicting protein interaction networks from gene expression data can provide valuable insights into normal and disease biology. For example, the resulting protein networks can be used to identify potentially druggable targets and drug candidates for testing in cell and animal disease models. The advent of whole-transcriptome expression profiling techniques—that catalogue protein-coding genes expressed within cells and tissues—has enabled development of individual algorithms for particular tasks. For example,: (i) gene ontology algorithms that predict gene/protein subsets involved in related cell processes; (ii) algorithms that predict intracellular protein interaction pathways; and (iii) algorithms that correlate druggable protein targets with known drugs and/or drug candidates. This review examines approaches, advantages and disadvantages of existing gene expression, gene ontology, and protein network prediction algorithms. Using this framework, we examine current efforts to combine these algorithms into pipelines to enable identification of druggable targets, and associated known drugs, using gene expression datasets. In doing so, new opportunities are identified for development of powerful algorithm pipelines, suitable for wide use by non-bioinformaticians, that can predict protein interaction networks, druggable proteins, and related drugs from user gene expression datasets.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
转录组学在预测蛋白质相互作用网络、药物靶点和候选药物中的应用
蛋白质相互作用途径和网络对于广泛的生物过程是至关重要的。在特定的细胞、组织和疾病环境中改进候选药物蛋白的发现将有助于开发新的治疗方法。从基因表达数据预测蛋白质相互作用网络可以为正常和疾病生物学提供有价值的见解。例如,由此产生的蛋白质网络可用于识别潜在的可药物靶点和候选药物,以便在细胞和动物疾病模型中进行测试。全转录组表达谱技术的出现——对细胞和组织内表达的蛋白质编码基因进行编目——使得针对特定任务的个人算法得以发展。例如:(i)预测参与相关细胞过程的基因/蛋白质子集的基因本体算法;(ii)预测细胞内蛋白质相互作用途径的算法;以及(iii)将可药物蛋白靶点与已知药物和/或候选药物相关联的算法。本文综述了现有的基因表达、基因本体和蛋白质网络预测算法的方法、优缺点。利用这一框架,我们研究了目前将这些算法结合到管道中的努力,以便使用基因表达数据集识别可药物靶标和相关已知药物。在此过程中,为开发强大的算法管道确定了新的机会,适合非生物信息学家广泛使用,可以从用户基因表达数据集预测蛋白质相互作用网络,可药物蛋白质和相关药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
0
审稿时长
13 weeks
期刊最新文献
Open-loop narrowband magnetic particle imaging based on mixed-frequency harmonic magnetization response. A prototype photoplethysmography-based cuffless device shows promising results in tracking changes in blood pressure. Motion artifact variability in biomagnetic wearable devices. Advancements in sarcopenia diagnosis: from imaging techniques to non-radiation assessments. Towards non-invasive imaging through spinal-cord generated magnetic fields.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1